Development and validation of a scoring system for predicting cancer patients at risk of extended-spectrum b-lactamase-producing Enterobacteriaceae infections.
Álvaro José MartínezBrian J Gómez MartínezAnita M Montañez AyalaKatherin GarcíaRicardo Sánchez PedrazaLeydy P Jiménez CetinaJulio C Gómez RincónSonia I Cuervo MaldonadoPublished in: BMC infectious diseases (2020)
Cancer patients have a high prevalence of risk factors for ESBL-PE infection. The scoring system did not adequately discriminate patients with ESBL-PE. In a high-risk population, other strategies should be sought to identify patients at risk of resistant ESBL-PE infection.